Item talk:Q168092: Difference between revisions
From geokb
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | { | ||
" | "OpenAlex": { | ||
"cited_by_count": 512355, | |||
"created_date": "2024-01-23", | |||
"description": "This cluster of papers focuses on the management and treatment of hemophilia, including prophylaxis, inhibitors, gene therapy, and the impact on joint health. It covers a wide range of topics such as recombinant factor VIII, factor IX, and the safety and efficacy of various treatment strategies.", | |||
"display_name": "Management and Treatment of Hemophilia", | |||
"domain": { | |||
"id": "https://openalex.org/domains/4", | |||
"display_name": "Health Sciences" | |||
"display_name": " | |||
}, | }, | ||
{ | "field": { | ||
"id": "https://openalex.org/ | "id": "https://openalex.org/fields/27", | ||
"display_name": " | "display_name": "Medicine" | ||
}, | }, | ||
{ | "id": "https://openalex.org/T11280", | ||
" | "ids": { | ||
" | "openalex": "https://openalex.org/T11280", | ||
"wikipedia": "https://en.wikipedia.org/wiki/Hemophilia_management" | |||
}, | }, | ||
{ | "keywords": [ | ||
"id": "https://openalex.org/T11215", | "Hemophilia", | ||
"Factor VIII", | |||
"Prophylaxis", | |||
"Inhibitors", | |||
"Recombinant Factor VIIa", | |||
"Gene Therapy", | |||
"Joint Disease", | |||
"Coagulation Disorders", | |||
"Efficacy", | |||
"Safety" | |||
], | |||
"siblings": [ | |||
{ | |||
"id": "https://openalex.org/T10309", | |||
"display_name": "Acute Myeloid Leukemia" | |||
}, | |||
{ | |||
"id": "https://openalex.org/T10649", | |||
"display_name": "Diagnosis and Treatment of Multiple Myeloma" | |||
}, | |||
{ | |||
"id": "https://openalex.org/T11660", | |||
"display_name": "Diseases Related to Blood Group Variants" | |||
}, | |||
{ | |||
"id": "https://openalex.org/T11215", | |||
"display_name": "Efficacy and Resistance in CML Treatment" | |||
}, | |||
{ | |||
"id": "https://openalex.org/T10345", | |||
"display_name": "Hematopoietic Stem Cell Biology" | |||
}, | |||
{ | |||
"id": "https://openalex.org/T11616", | |||
"display_name": "Hemophagocytic Lymphohistiocytosis and Related Disorders" | |||
}, | |||
{ | |||
"id": "https://openalex.org/T12548", | |||
"display_name": "Hemostatic Agents and Techniques" | |||
}, | |||
{ | |||
"id": "https://openalex.org/T10746", | |||
"display_name": "Platelet Disorders and Thrombosis Mechanisms" | |||
}, | |||
{ | |||
"id": "https://openalex.org/T10452", | |||
"display_name": "Regulation of Iron Metabolism and Anemia" | |||
}, | |||
{ | |||
"id": "https://openalex.org/T11534", | |||
"display_name": "Role of Erythropoietin in Disease Treatment and Management" | |||
}, | |||
{ | |||
"id": "https://openalex.org/T10881", | |||
"display_name": "Thrombosis and Coagulation Disorders" | |||
} | |||
], | |||
"subfield": { | |||
"id": "https://openalex.org/subfields/2720", | |||
"display_name": "Hematology" | |||
}, | }, | ||
"updated_date": "2024-08-19T06:15:38.934723", | |||
"works_count": 39682, | |||
"oa_id": "T11280" | |||
} | |||
} | } |
Latest revision as of 21:20, 12 September 2024
{
"OpenAlex": { "cited_by_count": 512355, "created_date": "2024-01-23", "description": "This cluster of papers focuses on the management and treatment of hemophilia, including prophylaxis, inhibitors, gene therapy, and the impact on joint health. It covers a wide range of topics such as recombinant factor VIII, factor IX, and the safety and efficacy of various treatment strategies.", "display_name": "Management and Treatment of Hemophilia", "domain": { "id": "https://openalex.org/domains/4", "display_name": "Health Sciences" }, "field": { "id": "https://openalex.org/fields/27", "display_name": "Medicine" }, "id": "https://openalex.org/T11280", "ids": { "openalex": "https://openalex.org/T11280", "wikipedia": "https://en.wikipedia.org/wiki/Hemophilia_management" }, "keywords": [ "Hemophilia", "Factor VIII", "Prophylaxis", "Inhibitors", "Recombinant Factor VIIa", "Gene Therapy", "Joint Disease", "Coagulation Disorders", "Efficacy", "Safety" ], "siblings": [ { "id": "https://openalex.org/T10309", "display_name": "Acute Myeloid Leukemia" }, { "id": "https://openalex.org/T10649", "display_name": "Diagnosis and Treatment of Multiple Myeloma" }, { "id": "https://openalex.org/T11660", "display_name": "Diseases Related to Blood Group Variants" }, { "id": "https://openalex.org/T11215", "display_name": "Efficacy and Resistance in CML Treatment" }, { "id": "https://openalex.org/T10345", "display_name": "Hematopoietic Stem Cell Biology" }, { "id": "https://openalex.org/T11616", "display_name": "Hemophagocytic Lymphohistiocytosis and Related Disorders" }, { "id": "https://openalex.org/T12548", "display_name": "Hemostatic Agents and Techniques" }, { "id": "https://openalex.org/T10746", "display_name": "Platelet Disorders and Thrombosis Mechanisms" }, { "id": "https://openalex.org/T10452", "display_name": "Regulation of Iron Metabolism and Anemia" }, { "id": "https://openalex.org/T11534", "display_name": "Role of Erythropoietin in Disease Treatment and Management" }, { "id": "https://openalex.org/T10881", "display_name": "Thrombosis and Coagulation Disorders" } ], "subfield": { "id": "https://openalex.org/subfields/2720", "display_name": "Hematology" }, "updated_date": "2024-08-19T06:15:38.934723", "works_count": 39682, "oa_id": "T11280" }
}